Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Cell|November 1, 1980
Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxicD B Cawley, H R Herschman, D G Gilliland, et al.
The Journal of Clinical Investigation|October 15, 1996
Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplantD Lajeunesse, L Busque, P Ménard, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1978
Chimeric toxins: toxic, disulfide-linked conjugate of concanavalin A with fragment A from diphtheria toxinD G Gilliland, R J Collier, J M Moehring, et al.
Molecular and Cellular Biology|April 21, 2001
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradationJ Frantsve, J Schwaller, D W Sternberg, et al.
Cancer|January 15, 1994
Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survivalK K Ballen, D G Gilliland, L A Kalish, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reactionD G Gilliland, K L Blanchard, J Levy, et al.
Journal of Clinical Microbiology|May 31, 2002
Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimensC Guilbault, A-C Labbé, L Poirier, et al.
Journal of Forensic Sciences|December 16, 1997
Analysis of allele distribution for six short tandem repeat loci in the French Canadian population of QuébecL Busque, D Desmarais, S Provost, et al.
Bone Marrow Transplantation|January 2, 1997
Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulinS J Lee, W H Churchill, A Konugres, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathwaysM Carroll, M H Tomasson, G F Barker, et al.
Pageof 10